Pharmaxis Ltd. announced the appointment of experienced senior global pharma executive Dr Simon Green to the Board as an independent nonexecutive director. Dr Green has 30 years of experience in the biotechnology industry focused on the discovery, development and commercialization of life saving medicines. He worked in the USA at leading biotechnology companies Genentech Inc. and Chiron Corporation prior to joining CSL in 1998.

Dr Green was actively involved in CSL's global expansion over a 17 year period and held roles as Senior Vice President, Global Plasma R&D and General Manager of CSL's manufacturing plants in Germany and Australia. Dr Green's breadth of skills covers R&D drug development, corporate due diligence, mergers and acquisitions, strategic planning, portfolio management, financial management, intellectual property management, business development, contract management and organizational design. Dr Green was educated at Monash University (Bachelor's Degree with Honours) and the University of Melbourne (Doctor of Philosophy, Biochemistry and Immunology).

He is a graduate of the Australian Institute of Company Directors Company Directors Course. Dr Green is a nonexecutive director of Clover Corporation Limited and is the founder and CEO of Immunosis Pty Ltd, a startup diagnostics Company. He is also a Venture Partner and investment advisor at BioScience Managers, a healthcare investment firm and serves on the scientific advisory board for Imunexus Pty Ltd. Dr Green is based in Melbourne Australia and will take up his role as nonexecutive director on 16 December 2022.